These characteristics of LSAMP defects are evident in reports on clear cell renal cell carcinoma, lung adenocarcinoma, prostatic adenocarcinoma, osteosarcoma, neuroblastoma, acute myeloid leukemia, and epithelial ovarian cancer (Table 1). This evidence concerns the gene LSAMP and prostate adenocarcinoma.